LIVE | Moderna develops booster vaccine for omicron variant | Inland

Corona crisis: Friday 26 November

–

AMSTERDAM – The American biotech company Moderna is developing a booster vaccine for the Omicron variant of the coronavirus, which was labeled as worrying by the World Health Organization on Friday. Earlier, Moderna had already developed boosters for the beta and delta variants of the virus. The company says it can have a vaccine ready for clinical studies within 60 to 90 days.